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http://dx.doi.org/10.1016/j.jmii.2013Objective: To investigate the etiologies and antibiotic susceptibility of community-acquired
bacteremia in infants in a medical center in northern Taiwan.
Methods: We conducted a retrospective analysis of all blood cultures from infants in the Na-
tional Taiwan University Hospital from 2002 to 2011 to find community-acquired bacteremia.
Common pathogens, antibiotic resistance, and outcome were analyzed.
Results: During the study period, 25,628 blood cultures were collected, and 3.4% of the cul-
tures were positive, of which 15.9% were categorized as community-acquired bacteremia. In
the age group of 0e6-days, the leading causative organisms were group B streptococcus
(41.7%) and Escherichia coli (30.6%). In the 7e90-days and 4e6-months groups, the most com-
mon pathogens were E. coli (44.1%, 45.5%, respectively) and group B streptococcus (32.4%,
13.6%, respectively). For infants aged 7e12 months, the most common pathogens were Salmo-
nella species (51.1%) and E. coli (12.8%). The overall mortality rate of community-acquired
bacteremia was 6%. Urinary tract infection was the concomitant diagnosis among 52.4% of in-
fants with E. coli bacteremia. Meningitis was found in 33.3% of infants with group Bediatric Infectious Diseases, Department of Pediatrics, National Taiwan University Hospital, College of
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414 Y.-T. Ting et al.streptococcus bacteremia. Listeria monocytogenes bacteremia was identified in three infants,
one of whom had meningitis. Penicillin resistance was found in 4% of group B streptococcus and
ampicillin resistance in 71% of E. coli.
Conclusion: Our study provides updated etiological data on community-acquired bacteremia in
infants in northern Taiwan. Group B streptococcus and E. coli remained the leading pathogens
in infants aged 6 months or younger and Salmonella species for those older than 6 months.
Copyright ª 2013, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. All rights
reserved.Introduction
Bacteremia is a frequent and important cause of neonatal
and infant morbidity and mortality.1e3 The currently rec-
ommended treatment is ampicillin and gentamicin for young
infant bacteremia and third-generation cephalosporins for
older infants with suspected sepsis.1,4e6 The evidence to
recommend empirical antibiotics in infants with community-
acquired bacteremia in Taiwan has been limited because of a
lack of comprehensive data on common bacterial pathogens
and antimicrobial resistance after 2003.
To investigate the etiologies and antibiotic susceptibility
of community-acquired bacteremia in neonates and in-
fants, we thus reviewed microbiological data from blood
cultures taken from infants aged 12 months or younger
during a 10-year period (2002e2011) at the National Taiwan
University Hospital (NTUH), a tertiary medical center with
2500 beds located in Northern Taiwan.
Methods
Patient and bacterial isolates
We performed a retrospective analysis of all blood cultures
from infants at NTUH during 2002e2011. All the electronic
medical records of infants with positive blood cultures were
analyzed. We reviewed the demography, underlying dis-
eases, date of blood sampling, date of hospitalization,
laboratory data, clinical presentations, and outcomes.
For antimicrobial susceptibility, isolates were classified as
beingeither susceptibleor resistant to anantimicrobial agent
using the disc diffusion method and/or minimum inhibitory
concentration. The results were interpreted according to
Clinical and Laboratory Standards Institute guidelines.
The number of deliveries every year in our hospital was
obtained from the obstetrics department to calculate the
rate of neonatal early-onset group B streptococcus (GBS)
infection in our hospital.
Definitions
Bacteremia was defined as the isolation of at least one non-
contaminant bacteria from the blood culture. Bacillus spe-
cies,micrococci, orCorynebacterium species grownalone ina
single culturewere categorized as contaminants,7e9 andwere
thus excluded in this study. Coagulase-negative staphylo-
coccus species (CoNS) would be considered true pathogens
among neonates and premature babies if there was one ormoreclinical signs of neonatal sepsis (temperature instability,
cardiorespiratory signs, gastrointestinal disturbance, leth-
argy, or irritability) in infants who had an isolation of CoNS
(same species and/or identical antimicrobial susceptibility
results) from two or more blood cultures or from one blood
culture and a sterile body site.10 Infections were classified as
nosocomial episodes, which would be excluded in this study if
they first appeared 48 hours or more after hospitalization or
within 14 days after discharge.10e12 We also excluded the
bacteremic neonates whose mothers had been admitted to
our hospital for delivery, and the bacteremic premature ba-
bies with prolonged hospital stay.
To assess concomitant urinary tract infection (UTI), men-
ingitis, and gastroenteritis, urinary, cerebrospinal fluid (CSF),
and stool culture results were evaluated if the aforemen-
tioned cultures were obtained within 2 days of blood culture
sampling in all infantswith clinically significant bacteremia.2,3
UTIwas definedas voidingurine culturewith100,000 colony-
forming units of a single organism per milliliter and cathe-
terized urine culture 10,000 colony-forming units of a single
organism per milliliter, respectively. Bacterial meningitis was
defined as a positive CSF culture or a positive blood culture
with CSF pleocytosis. Gastroenteritiswas definedas increased
frequency or amount of stool passage with positive results of
rotaviral or noroviral antigen by enzyme-linked immunosor-
bent assay or stool cultures.
The age groups of patients were divided as follows: 0e6-
days, 7e90-days, and 4e6-months (91e180 days old) and
7e12-months (181e365 days old) groups. Leukopenia was
defined as leukocyte count less than 4000/mL, thrombocy-
topenia was defined as platelet count less than 100,000/mL,
and extremely low birth weight was defined as birth body
weight (BBW) less than 1000 g. Fatality was defined as
death within 14 days of a positive blood culture.
Statistics
Data were shown with medium (range), percentages, and
numbers. We used the Chi-square test to calculate the p
values of risk factors associated with mortality. A p value
<0.05 was considered statically significant.
Results
Study population and patient characteristics
During the 10-year study period, 25,628 blood cultures were
performed on infants. A total of 1224 organisms were
Figure 1. Causes of community-acquired bacteremia by age
group.
Epidemiology of community-acquired bacteria 415recovered from blood samples. Of these, 339 isolates were
categorized as contaminants (27.7%), whereas 139 clinically
significant episodes of community-acquired bacteremia
(11.4%) were identified. The other 746 (60.9%) episodes
were nosocomial infections.
Of these 139 patients with community-acquired bacter-
emia, 35% of patients were female, and the male-to-female
ratio was 1.8 (90:49). Regarding the age group, the 0e6-
days group consisted of 36 patients (26%), the 7e90-days
group had 34 patients (24%), the 4e6-months group had 22
patients (16%), and the 7e12-months group had 47 patients
(34%; Table 1). The most frequent underlying conditions
were prematurity in 25 patients (18%), biliary atresia in 13
patients (9.4%), and congenital heart disease (CHD) in 7
patients (5%). No patient had immunodeficiency or
hematology-oncology diseases.
The overall fatality rate was 6% (9/139). There was no
significant difference in the mortality rates between
2002e2006 and 2007e2012. Early-onset infection (infant
age younger than 7 days) was a risk factor of mortality (6/9
vs. 30/100, p Z 0.01). Other risk factors of mortality
included prematurity with gestational age less than 36
weeks (3/9 vs. 13/124, p Z 0.04), BBW lower than 1,500 g
(3/9 vs. 9/120, p Z 0.01), no fever (6/9 vs. 32/130,
pZ 0.006), leukopenia (leukocyte count<4000/mL; 3/9 vs.
10/118, p Z 0.02), and thrombocytopenia (platelet
count<100,000/mL; 3/5 vs. 9/124, p < 0.001).
Clinical features of important pathogens
All the episodes were monomicrobial infections. Gram-
positive pathogens predominated the community-acquired
bacteremia only in the 0e6-days group (55.6%) and then
decreased inproportion as thepatients’ age increased. In the
age group of 0e6 days of life, group B streptococcus (GBS;
also known as Streptococcus agalactiae) was the most com-
mon agent, accounting for 41.7% of all episodes, followed by
E. coli (30.6%) and Listeriamonocytogenes (8.3%; Fig. 1). For
patients aged 7e90 days and 4e6 months, E. coli was the
leading cause of bacteremia (44.1% and 45.5%, respectively),
and GBS was the second most common agent (32.4% and
13.6%, respectively). Salmonella species accounted for half
of the episodes in the 7e12-months age group (51.1%), whichTable 1 Characteristics and underlying comorbidities by
age group
N (%)
Age group 0e90 d 4e6 mo 7e12 mo Overall
70 (50) 22 (16) 47 (34) 139 (100)
Male 50 (71) 13 (59) 27 (57) 90 (65)
Prematurity 16 (23) 5 (23) 4 (9) 25 (18)
CHD 3 (4) 3 (14) 1 (2) 7 (5)
GI abnormality 1 (1) 5 (23) 9 (19) 15 (11)
BA 0 (0) 5 (23) 8 (17) 13 (9)
Others 1 (1) 0 (0) 1 (2) 2 (1)
Others 1a (1) 0 (0) 0 (0) 1 (0.7)
a Perinatal asphyxia, hypoxic ischemic encephalopathy.
BA Z biliary atresia; CHD Z congenital heart disease;
GI Z gastrointestinal.was four times the second most common organism, E. coli
(12.8%), in this age group. Staphylococcus aureus and
Streptococcus pneumoniae were the next most common
pathogens in this group (8.5% and 8.5%, respectively).
Regardless of the patients’ age, E. coli bacteremia
eventually predominated these community-acquired epi-
sodes (42/139, 30%). Of the 42 infants with E. coli bacter-
emia, 23 (54.8%) and 5 (12%) had concomitant UTI or
meningitis (Table 2). Cases with concomitant UTI had a
significantly lower rate of gestational age <28 weeks (0/24
vs. 4/17, pZ 0.01), a significantly higher rate of fever (24/
24 vs. 0/18, p < 0.0001), and a significantly higher rate with
C-reactive protein over 5 mg/dL (13/23 vs. 0/17,
p Z 0.0002). Seventy-four percent (17/23) of the patients
with UTI were male. The mortality rate of E. coli bacter-
emia was 4.8% (2/42). Extreme low birth weight
(BBW < 1000 g; 1/2 vs. 1/39, p Z 0.002), no fever (2/2 vs.
6/40, pZ 0.003), and leukopenia (1/2 vs. 1/37, pZ 0.003)
were risk factors of mortality in cases of E. coli bacteremia.
Of 30 cases with GBS bacteremia, 15 (50%) were early-
onset neonatal bacteremia, and 11 (36.7%) had concomi-
tant meningitis. In the cases with concomitant meningitis,
lower rate of prematurity (either gestational age less than
36 weeks or 32 weeks; 0/11 vs. 7/19, pZ 0.02; 0/11 vs. 6/
19, p Z 0.04, respectively), more febrile patients (10/11
vs. 7/19, p Z 0.004), higher rates of leukopenia (5/11 vs.
2/19, p Z 0.03) and elevated serum C-reactive protein
level (>5 mg/dL: 6/11 vs. 0/19, pZ 0.0003; >10 mg/dL: 4/
11 vs. 0/19, pZ 0.005) were noted. Two patients (7%) died.
Salmonella was the most common in the 7e12-months
age group. Among the 25 cases with Salmonella bacter-
emia, 15 cases (60%) had concomitant gastroenteritis and
no death occurred. Female babies with Salmonella
bacteremia had a higher rate of gastroenteritis than males
according to our data (p Z 0.045).
There were one case of Haemophilus influenzae type B
bacteremia and one case with Neisseria meningitidis
bacteremia. Both cases had concomitant bacterial
meningitis.
Drug susceptibility
Thirty (71%) of 42 E. coli isolates were ampicillin resistant
and 6 (42%) were gentamicin resistant. Five of six
Table 2 Bacterial pathogens in 139 infants with community-acquired bacteremia
N (%) Median age in d (range) UTI Concomitant
meningitis
AGE/colitis Mortality
Gram-positive 50 (36)
GBS 30 (22) 6 (0e197) 1 (3) 10 (33) 0 (0) 5 (17)
Staphylococcus aureus 6 (4) 232.5 (79e340) 0 (0) 0 (0) 0 (0) 0 (0)
Streptococcus pneumoniae 6 (4) 246 (52e297) 0 (0) 1 (17) 0 (0) 1 (17)
Listeria monocytogenes 3 (2) 1 (0e1) 0 (0) 1 (33) 0 (0) 0 (0)
Enterococcus spp. 2 (1) 211 (159e262) 0 (0) 0 (0) 0 (0) 0 (0)
Gram-negative 89 (64)
Escherichia coli 42 (30) 66.5 (0e363) 22 (52) 5 (12) 4 (10) 1 (2)
Salmonella spp. 25 (18) 271 (137e361) 2 (8) 1 (4) 13 (52) 0 (0)
Klebsiella spp. 7 (5) 53 (4e298) 3 (43) 0 (0) 1 (14) 1 (14)
Pseudomonas spp. 3 (2) 195 (176e313) 0 (0) 0 (0) 0 (0) 1 (33)
AGE Z acute gastroenteritis; GBS Z group B streptococcus; UTI Z urinary tract infection.
416 Y.-T. Ting et al.gentamicin-resistant strains (83%) were also ampicillin
resistant, and two isolates were resistant to cefotaxime,
one of which had extended-spectrum beta-lactamase. If we
divided the antibiotic resistance data into two parts,
2002e2006 and 2007e2012, and compared the change in
the resistant rate of each antibiotic agent, there was no
significant difference in the rate of resistance to ampicillin,
cefazoline, cefmetazole, and cefotaxime. However, a
significantly decreased rate of resistance to gentamicin was
noted, from 45% to 3% (p Z 0.003).
In 30 GBS strains, only one strain (4%) was recorded as
penicillin resistant. Five strains (20%) of Salmonella species
were ampicillin-resistant strains, whereas none were
resistant to the third-generation cephalosporins. The rates
of resistance to ampicillin, ciprofloxacin, and
trimethoprim-sulfamethoxazole did not show significant
difference between 2002e2006 and 2007e2012.
All three isolates of L. monocytogenes were susceptible
to ampicillin. One isolate (14%) of Klebsiella pneumoniae
was resistant to gentamicin. Four isolates of S. aureus were
recovered after 2006, of which 3 (75%) were methicillin
resistant.Discussion
As the incidence of antimicrobial resistance increases,
updated data on species distribution and resistance pat-
terns of community-acquired pathogens become important
to provide the basis for appropriate empirical therapy.12
Our study showed that community-acquired bacteremia in
infants happened mainly in the 0e90-days age group. 0e6-
days and 7e90-days age groups consisted of similar case
numbers. GBS and E. coli remained the two leading caus-
ative pathogens in these two age groups, whereas Salmo-
nella species predominated in the 7e12-month group.
For all the Gram-negative pathogens with available
data, 49 (62%) of 70 isolates were ampicillin resistant and 7
(12%) of 58 isolates were gentamicin resistant. In E. coli
strains, the susceptibility rates of cefazolin, ampicillin plus
gentamicin, and ampicillin plus cefotaxime were 73%, 88%,
and 95%, respectively (Fig. 2). However, 97% of GBS strainswere susceptible to ampicillin plus gentamicin. There was
no cefotaxime or ceftriaxone-resistant Salmonella species
in our data. Three of 4 strains S. pneumoniae (75%) were
penicillin resistant. Half of the S. aureus strains were
methicillin resistant. The only Neisseria meningitides strain
was penicillin-intermediate but cefotaxime susceptible. H.
influenzae type B was susceptible to ampicillin. For all
pathogens, the susceptible rates of ampicillin, gentamicin,
and cefotaxime/ceftriaxone were 50%, 40%, and 84%,
respectively. The coverage rate of combination therapy
with ampicillin plus gentamicin was similar to that with
ampicillin plus cefotaxime (81% vs. 86%, respectively). The
antimicrobial susceptibility of some isolates was incom-
plete and unavailable for repeated checkup. Thus, the rate
of drug resistance could be higher. Therefore, this finding
emphasized the need to revise the use of ampicillin as
initial antibiotics in infants with suspected bacteremia in
Taiwan because the common pathogens (such as GBS, E.
coli, Salmonella species) of infant bacteremia were
frequently resistant to ampicillin. Because 84% of all
pathogens are susceptible to third-generation cephalo-
sporin, it may be considered as the initial antibiotic for
infant sepsis or bacteremia to cover the most common
pathogens.
GBS had been considered the most common pathogen in
young infants, especially in those with early-onset neonatal
sepsis. E. coli, instead, was the leading cause of late-onset
bacteremia. In our data, a decreasing trend of GBS
bacteremia in neonates age 6 days or younger was
observed. There was no apparently yearly decrease in our
total case number. Gram-negative organisms accounted for
a high percentage of all bacteremia episodes. The yearly
decrease in the total number of newborns born in Taiwan
could not explain the phenomenon of “pathogen-switch-
ing”. Since the adoption of the 1996 consensus guidelines
for intrapartum antibiotic prophylaxis, the incidence of GBS
early-onset sepsis has declined by 65% (from 1.7 per 1000 to
0.6 per 1000) in the United States.13 According to a previous
study, the incidences of GBS infection during 1980 and 2000
had no obvious change and varied from 0.25 cases per 1000
live births to 0.9 cases per 1000 live births.14 In our data,
there were a total of 26 cases of GBS infection in young
Figure 2. Drug susceptibility of Escherichia coli, group B streptococcus, Salmonella species, and all pathogens.
AMPZ ampicillin; CZZ cefazolin; CROZ ceftriaxone; CTXZ cefotaxime; GMZ gentamicin; LVXZ levofloxacin; PZ penicillin;
SXT Z sulfamethoxazole.
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infection in young infants ranged from 0 cases per 1000 live
births to 2.2 cases per 1000 live births during the 10-year
study period. Early-onset infection accounted for 58% of
these GBS infections. The promotion of GBS screening
during pregnancy started in 1996 but this test had been
self-paid until January 2012. Some studies have seen a
correlation with intrapartum antibiotics and the risk for
late-onset serious bacterial infections and ampicillin-
resistant pathogens.15,16 The effect of maternal screening
for GBS and the resultant increased use of intrapartum
prophylaxis on the epidemiology of infant bacteremia in
Taiwan needs further investigation.
Our study had some limitations. This was a retrospective
review of electronic medical records of all blood cultures
obtained in infants aged 12 months or younger. First, some
baseline data might be incomplete, such as the underlying
diseases, presence of central catheter (e.g., Hickman cath-
eter), date of previous admission at any hospital, or previous
antibiotic usage. Without this information, we might over-
estimate or underestimate the incidence of community-
acquired bacteremia. Second, acquisition of a blood culture
was at the clinician’s discretion. The numbers of blood cul-
tures and the amount of blood sample taken in each patient
were varied. A smaller blood sample could lower the positive
rate of blood cultures. Third, some blood samples of patients
with positive blood culture, not contaminants, were taken at
our emergent department but these patients were neither
admitted nor followed up at our outpatient department. We
could not evaluate concomitant diseases and outcomes.
Fourth, our studywas not amulticenter study andmay not be
able to withstand all the resistant patterns nationwide.
In conclusion, GBS and E. coli remain the leading path-
ogens of community-acquired bacteremia in infants aged 6months or younger and Salmonella species for those older
than 6 months in northern Taiwan. Antibiotic resistance was
common, so empirical antibiotics for infant bacteremia or
sepsis may be revised in the future.
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